Patients share their experiences with hepatitis C treatment for Per-SVR study
Through its Per-SVR study (pronounced “persevere”) the BC-CfE is conducting important research todetermine thresholds of prevention methods, such as harm reduction and safer sexual practices, to prevent hepatitis C reinfection among key populations. Per-SVR is a multi-year study observing people who have been successfully treated for hepatitis C virus (HCV) with direct acting antiretrovirals (DAAs).
Patients share their experiences with hepatitis C treatment for Per-SVR study Read More »